{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:54:55Z","timestamp":1780646095295,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12149-020-01466-7","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T11:03:08Z","timestamp":1586948588000},"page":"441-447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiation exposure in nurses during care of 131I-MIBG therapy for pediatric patients with high-risk neuroblastoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Yuka","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anri","family":"Inaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Kayano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seigo","family":"Kinuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"1466_CR1","doi-asserted-by":"publisher","first-page":"189135","DOI":"10.1155\/2015\/189135","volume":"2015","author":"D Kayano","year":"2015","unstructured":"Kayano D, Kinuya S. Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective. Sci World J. 2015;2015:189135. https:\/\/doi.org\/10.1155\/2015\/189135.","journal-title":"Sci World J"},{"key":"1466_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/Hp.0000000000000905","volume":"115","author":"JA Barnes","year":"2018","unstructured":"Barnes JA, de la Guardia M, Easley T, Downs H, Mims S, Nielson K, et al. Radiation safety aspects of Iodine-131 metaiodobenzylguanidine (131I mIBG) therapy program startup. Health Phys. 2018;115:776\u201386. https:\/\/doi.org\/10.1097\/Hp.0000000000000905.","journal-title":"Health Phys"},{"key":"1466_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4172\/2155-9619.1000258","volume":"6","author":"T Hjornevik","year":"2015","unstructured":"Hjornevik T, Martinsen AC, Hagve WE, Andersen MW, M\u00f8rk AC, Fjeld JG, et al. Experiences from introducing standardized high dose 131I-mIBG treatment of children with refractory neuroblastoma: differences in effective dose to patients and exposure to caregivers. J Nucl Med Radiat Ther. 2015;6:6. https:\/\/doi.org\/10.4172\/2155-9619.1000258.","journal-title":"J Nucl Med Radiat Ther"},{"key":"1466_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/RLU.0b013e31829af3c8","volume":"38","author":"RJ Markelewicz Jr","year":"2013","unstructured":"Markelewicz RJ Jr, Lorenzen WA, Shusterman S, Grant FD, Fahey FH, Treves ST. Radiation exposure to family caregivers and nurses of pediatric neuroblastoma patients receiving 131I-metaiodobenzylguanidine (131I-MIBG) therapy. Clin Nucl Med. 2013;38:604\u20137. https:\/\/doi.org\/10.1097\/RLU.0b013e31829af3c8.","journal-title":"Clin Nucl Med"},{"key":"1466_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/RLU.0000000000002158","volume":"43","author":"J Willegaignon","year":"2018","unstructured":"Willegaignon J, Crema KP, Oliveira NC, Pelissoni RA, Coura-Filho GB, Sapienza MT, et al. Pediatric 131I-MIBG therapy for neuroblastoma: whole-body 131I-MIBG clearance, radiation doses to patients, family caregivers, medical staff, and radiation safety measures. Clin Nucl Med. 2018;43:572\u20138. https:\/\/doi.org\/10.1097\/RLU.0000000000002158.","journal-title":"Clin Nucl Med"},{"key":"1466_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/RLU.0000000000001546","volume":"42","author":"S Han","year":"2017","unstructured":"Han S, Yoo SH, Koh KN, Lee JJ. Estimated internal and external radiation exposure of caregivers of patients with pediatric neuroblastoma undergoing 131I metaiodobenzylguanidine therapy: a prospective pilot study. Clin Nucl Med. 2017;42:271\u20134. https:\/\/doi.org\/10.1097\/RLU.0000000000001546.","journal-title":"Clin Nucl Med"},{"key":"1466_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/pbc.25892","volume":"63","author":"BP Chu","year":"2016","unstructured":"Chu BP, Horan C, Basu E, Dauer L, Williamson M, Carrasquillo JA, et al. Feasibility of administering high-dose (131) I-MIBG therapy to children with high-risk neuroblastoma without lead-lined rooms. Pediatr Blood Cancer. 2016;63:801\u20137. https:\/\/doi.org\/10.1002\/pbc.25892.","journal-title":"Pediatr Blood Cancer"},{"key":"1466_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/rpd\/ncw030","volume":"173","author":"O Cougnenc","year":"2017","unstructured":"Cougnenc O, Defachelles AS, Carpentier P, Lervat C, Clisant S, Oudoux A, et al. High-dose 131I-MIBG therapies in children: feasibility, patient dosimetry and radiation exposure to workers and family caregivers. Radiat Prot Dosim. 2017;173:395\u2013404. https:\/\/doi.org\/10.1093\/rpd\/ncw030.","journal-title":"Radiat Prot Dosim"},{"key":"1466_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/pbc.25250","volume":"62","author":"JE Gains","year":"2015","unstructured":"Gains JE, Walker C, Sullivan TM, Waddington WA, Fersht NL, Sullivan KP, et al. Radiation exposure to comforters and carers during paediatric molecular radiotherapy. Pediatr Blood Cancer. 2015;62:235\u20139. https:\/\/doi.org\/10.1002\/pbc.25250.","journal-title":"Pediatr Blood Cancer"},{"key":"1466_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2478\/pjmpe-2018-0019","volume":"24","author":"K Chuamsaamarkkee","year":"2018","unstructured":"Chuamsaamarkkee K, Charoenphun P, Kamwang N, Monthonwattana S, Changmuang W, Thongklam K, et al. Radiation monitoring of non-lead-lined treatment room in general pediatric ward and adjacent areas for high dose 131Iodine-mIBG. J Pol Soc Med Phys. 2018;24:133\u20136. https:\/\/doi.org\/10.2478\/pjmpe-2018-0019.","journal-title":"J Pol Soc Med Phys"},{"key":"1466_CR11","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00259-008-0715-3","volume":"35","author":"F Giammarile","year":"2008","unstructured":"Giammarile F, Chiti A, Lassmann M, Brans B, Flux G. EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy. Eur J Nucl Med Mol Imaging. 2008;35:1039\u201347. https:\/\/doi.org\/10.1007\/s00259-008-0715-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1466_CR12","unstructured":"131I-MIBG Treatment for High-Risk Neuroblastoma. A Guide for Family Caregivers. https:\/\/www.sickkids.ca\/PDFs\/centres\/gfcc\/60936-SickKids%20MIBG%20Parent%20Education%20Guide.pdf. Accessed 26 Feb 2020."},{"key":"1466_CR13","unstructured":"Yokoi K, Togino Y, Yoshino T, Nagano M, Hyakuman M, Koshino M. An investigation of utility of care manual in 131I-MIBG treatment forpediatric patients (Japanese). In: Abstracts of the 47th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine, Kakuigaku, 2007. p. 324."},{"key":"1466_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s12149-015-0960-z","volume":"29","author":"S Kinuya","year":"2015","unstructured":"Kinuya S, Yoshinaga K, Higuchi T, Jinguji M, Kurihara H, Kawamoto H. Draft guidelines regarding appropriate use of (131)I-MIBG radiotherapy for neuroendocrine tumors: Guideline Drafting Committee for Radiotherapy with (131)I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine. Ann Nucl Med. 2015;29:543\u201352. https:\/\/doi.org\/10.1007\/s12149-015-0960-z.","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-020-01466-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-020-01466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T10:04:20Z","timestamp":1618481060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-020-01466-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1466"],"URL":"https:\/\/doi.org\/10.1007\/s12149-020-01466-7","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"23 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"S.K. has a funded research project collaboration with FUJIFILM Toyama Chemical\u00a0Co., Ltd. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}